Arbutus Biopharma Corp - Common Shares, without par value (ABUS)

CUSIP: 03879J100

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Shares, without par value
Shares outstanding
197,420,670
Total 13F shares
24,142,348
Share change
+1,874,034
Total reported value
$75,528,504
Put/Call ratio
150%
Price per share
$3.13
Number of holders
60
Value change
+$7,771,699
Number of buys
37
Number of sells
28

Security key

03879J100

Report period

Q3 2020

Institutions

60

Top holders

10

Top shareholders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RTW INVESTMENTS, LP
13F
Company
3.5%
6,869,281
$12,502,000 30 Jun 2020
13F
COWEN AND COMPANY, LLC
13F
Company
2.2%
4,331,020
$7,882,000 30 Jun 2020
13F
MORGAN STANLEY
13F
Company
1.7%
3,353,537
$6,104,000 30 Jun 2020
13F
VANGUARD GROUP INC
13F
Company
0.92%
1,825,707
$3,323,000 30 Jun 2020
13F
OSAIC HOLDINGS, INC.
13F
Company
0.9%
1,774,815
$3,230,000 30 Jun 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.84%
1,664,331
$3,029,000 30 Jun 2020
13F
CITADEL ADVISORS LLC
13F
Company
0.68%
1,350,355
$2,458,000 30 Jun 2020
13F
Hudson Bay Capital Management LP
13F
Company
0.49%
975,000
$1,774,000 30 Jun 2020
13F
PRIMECAP MANAGEMENT CO/CA/
13F
Company
0.25%
500,000
$910,000 30 Jun 2020
13F
BANK OF MONTREAL /CAN/
13F
Company
0.24%
465,966
$867,000 30 Jun 2020
13F
JENNISON ASSOCIATES LLC
13F
Company
0.17%
339,639
$618,000 30 Jun 2020
13F
UBS Group AG
13F
Company
0.16%
324,292
$590,000 30 Jun 2020
13F
Squarepoint Ops LLC
13F
Company
0.16%
322,225
$586,000 30 Jun 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.16%
313,030
$569,000 30 Jun 2020
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.14%
283,507
$516,000 30 Jun 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.11%
222,573
$405,000 30 Jun 2020
13F
BlackRock Finance, Inc.
13F
Company
0.11%
214,276
$390,000 30 Jun 2020
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.08%
166,700
$303,000 30 Jun 2020
13F
LMR Partners LLP
13F
Company
0.05%
107,912
$196,000 30 Jun 2020
13F
JANE STREET GROUP, LLC
13F
Company
0.05%
106,181
$194,000 30 Jun 2020
13F
NORTHERN TRUST CORP
13F
Company
0.05%
102,787
$188,000 30 Jun 2020
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.03%
62,321
$113,000 30 Jun 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.03%
61,207
$111,000 30 Jun 2020
13F
Qube Research & Technologies Ltd
13F
Company
0.03%
58,913
$107,000 30 Jun 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.03%
54,599
$99,000 30 Jun 2020
13F
Russell Investments Group, Ltd.
13F
Company
0.02%
43,100
$78,000 30 Jun 2020
13F
MACKENZIE FINANCIAL CORP
13F
Company
0.02%
39,900
$73,000 30 Jun 2020
13F
Creative Planning
13F
Company
0.02%
32,748
$60,000 30 Jun 2020
13F
ETF MANAGERS GROUP, LLC
13F
Company
0.01%
20,520
$39,000 30 Jun 2020
13F
Virtu Financial LLC
13F
Company
0.01%
17,147
$31,000 30 Jun 2020
13F
ExodusPoint Capital Management, LP
13F
Company
0.01%
17,000
$31,000 30 Jun 2020
13F
A.R.T. Advisors, LLC
13F
Company
0.01%
14,140
$26,000 30 Jun 2020
13F
Cubist Systematic Strategies, LLC
13F
Company
0.01%
12,562
$23,000 30 Jun 2020
13F
SCOTIA CAPITAL INC.
13F
Company
0.01%
11,690
$21,000 30 Jun 2020
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
11,344
$21,000 30 Jun 2020
13F
WEDBUSH SECURITIES INC
13F
Company
0.01%
11,000
$20,000 30 Jun 2020
13F
Secure Asset Management, LLC
13F
Company
0.01%
10,000
$18,000 30 Jun 2020
13F
FNY Investment Advisers, LLC
13F
Company
0.01%
9,900
$18,000 30 Jun 2020
13F
ROYAL BANK OF CANADA
13F
Company
0%
8,269
$15,000 30 Jun 2020
13F
Sterling Investment Advisors, Ltd.
13F
Company
0%
4,000
$7,000 30 Jun 2020
13F
CITIGROUP INC
13F
Company
0%
2,946
$5,000 30 Jun 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
2,900
$5,000 30 Jun 2020
13F
CNB Bank
13F
Company
0%
1,045
$2,000 30 Jun 2020
13F
HARBOR INVESTMENT ADVISORY, LLC
13F
Company
0%
1,000
$2,000 30 Jun 2020
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0%
800
$1,456 30 Jun 2020
13F
TimeScale Financial, Inc.
13F
Company
0%
300
$1,000 30 Jun 2020
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
6
$11 30 Jun 2020
13F

Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q3 2020

As of 30 Sep 2020, Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,142,348 shares. The largest 10 holders included RTW INVESTMENTS, LP, Foresite Capital Management IV, LLC, MORGAN STANLEY, VANGUARD GROUP INC, Think Investments LP, ADVISOR GROUP HOLDINGS, INC., BlackRock Inc., Hudson Bay Capital Management LP, AMERIPRISE FINANCIAL INC, and PRIMECAP MANAGEMENT CO/CA/. This page lists 60 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
46
Q3 2020 holders
60
Holder diff
14
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .